Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Advancements in omics technologies
3.2.1.2 Increasing applications in personalized medicine
3.2.1.3 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments and data storage
3.2.2.2 Complex regulatory requirements and standardization issues
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Spatial transcriptomics
5.3 Spatial genomics
5.4 Spatial proteomics
Chapter 6 Market Estimates and Forecast, By Products, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Instruments
6.2.1 By Mode
6.2.1.1 Automated
6.2.1.2 Semi-automated
6.2.1.3 Manual
6.2.2 By Type
6.2.2.1 Sequencing platforms
6.2.2.2 IHC
6.2.2.3 Microscopy
6.2.2.4 Flow cytometry
6.2.2.5 Mass spectrometry
6.2.2.6 Other types
6.3 Consumables
6.4 Software
6.4.1 Bioinformatics tools
6.4.2 Imaging tools
6.4.3 Storage & management databases
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Diagnostics
7.3 Translation research
7.4 Drug discovery and development
7.5 Single cell analysis
7.6 Cell biology
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By Workflow, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Sample preparation
8.3 Instrumental analysis
8.4 Data analysis
Chapter 9 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Formalin-Fixed Paraffin-Embedded (FFPE)
9.3 Fresh frozen
Chapter 10 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 Academic & research institutes
10.3 Pharmaceutical and biotechnology companies
10.4 Contract research organizations
10.5 Other end-users
Chapter 11 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Netherlands
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 UAE
11.6.4 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 10x Genomics
12.2 Akoya Biosciences, Inc.
12.3 Bio-Techne Corporation
12.4 BioSpyder, Inc.
12.5 Bruker Corporation
12.6 Danaher Corporation
12.7 Diagenode Diagnostics (Hologic, Inc.)
12.8 Ionpath, Inc.
12.9 Millennium Science Pty Ltd.
12.10 NanoString Technologies, Inc.
12.11 PerkinElmer, Inc.
12.12 S2 Genomics, Inc.
